شحن متتبَّع إلى جميع أنحاء العالم | خلال 9–14 يوم عمل تقريبًا

سلتك

سلة التسوق فارغة

ابدأ التصفح

شحن مجاني على الطلبات التي تزيد عن €500.

المجموع الفرعي€0
المتابعة إلى الدفع
البشرةسريري مبكر

GHK-Cu

البحوث المنشورة وقاعدة الأدلة

GHK (glycyl-L-histidyl-L-lysine) is an endogenous human plasma tripeptide that binds copper(II) with high affinity. In cell culture it increases fibroblast collagen and glycosaminoglycan synthesis at picomolar to nanomolar concentrations, and gene-expression work reports broad modulation of extracellular-matrix, antioxidant and inflammatory programmes. Human data are limited: most published work is in vitro or in animal models, and the small number of controlled human trials of topical GHK-Cu have produced mixed results, including two randomised trials that found no advantage over comparator or placebo.

باختصار
  • GHK-Cu هو ثلاثي ببتيد بلازما بشري يرتبط بالنحاس(II).
  • أفادت دراسات خلوية بزيادة تخليق الكولاجين.
  • لم تجد تجربتان بشريتان عشوائيتان فائدة مقارنة بالعلاج الوهمي.

21 دراسة · 12 منذ 2023 · الأحدث 2026

الدراسات المذكورة
21
منشورة 2023+
12
أحدث ورقة بحثية
2026
آخر مراجعة
أكتوبر 2026

المواضيع المتكررة في الأدبيات

  • collagen synthesis
  • copper transport and chelation
  • extracellular matrix remodelling
  • glycosaminoglycan and elastin synthesis
  • wound healing and re-epithelialisation
  • antioxidant and anti-inflammatory gene modulation
  • topical peptide skin permeation

معرّفات المركب

PubChem
378611

الهوية الكيميائية

ما هو GHK-Cu، كيميائياً.

الصيغة الجزيئية
C14H24CuN6O4
الوزن الجزيئي
403.92 g/mol
PubChem CID
378611
يُكتب أيضاً كـ

Cu-GHK

هذه الأرقام مأخوذة من سجل PubChem لهذا المركب وتصف القاعدة الحرة. يتم توفير الببتيد المجفف بالتجميد عادةً كملح أسيتات أو ترايفلوروأسيتات ويحتوي على ماء متبقٍ، لذا فإن كتلة المسحوق في القارورة ليست نفس الكمية التي يشير إليها الوزن الجزيئي أعلاه. النقاء الكروماتوغرافي في شهادة التحليل لا يحل هذا الفرق أيضاً — كيفية قراءة شهادة التحليل يوضح السبب.

الأدلة

21 دراسة منشورة.

مرتبة حسب قوة تصميم الدراسة، ثم حسب الحداثة. كل إدخال يرتبط بالسجل المصدري حتى يمكن التحقق من النتيجة مقابل الورقة البحثية بدلاً من الاعتماد على كلامنا.

  1. 01مراجعة منهجية2026

    The Regenerative Potential of GHK-Cu in Aesthetic Medicine.

    Mokhtar J, et al. · Aesthetic Surgery Journal · PRISMA systematic review, database inception to March 2026; 20 eligible studies (18 preclinical, 2 RCTs)

    A systematic search identified only 20 studies of GHK-Cu as a standalone aesthetic intervention, of which 18 were preclinical and 2 were randomised controlled trials. The authors noted an absence of standardised clinical guidelines despite growing use in aesthetic practice.

  2. 02مراجعة منهجية2026

    GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.

    Mateescu DM, et al. · Pharmaceutics · structured systematic evidence-mapping review of PubMed, Europe PMC, ClinicalTrials.gov and EU/US/ICH regulatory sources to August 2026; no quantitative pooling

    Preclinical data consistently supported matrix remodelling, epithelial repair, anti-inflammatory/redox and angiogenic effects, but clinical evidence was sparse and did not meet active-entity quality standards. A 13-participant post-CO2-laser study was negative on objective endpoints, an 18-participant split-face eyebrow study was positive without defined copper speciation, and a phase 2 acute-wound trial (NCT07437586) had no results. The authors concluded that GHK-Cu remains a promising but unproven therapeutic agent.

  3. 03سريري بشري2026

    Peptide-enriched hydrogel formulation for sensitive and damaged skin: from design to application testing.

    Milena D, et al. · Scientific Reports · formulation development plus in vitro human skin cell assays and dermatological testing in human participants

    A hydrogel containing the NE1 peptide (which carries the bioactive GHK sequence) was stable and released approximately 75-80% of each peptide within the first hours. Dermatological testing in participants reported the composition to be safe; the study was designed as a cosmetic safety and application evaluation rather than an efficacy trial.

  4. 04سريري بشري2025

    Efficacy and Safety Assessment of ThriveCo Scar Fader Gel With Scarcede in the Treatment of Skin Scars.

    Patel MN, et al. · Cureus · open-label, interventional, prospective real-world study in females with acne scars

    An open-label study of a gel containing copper tripeptide-1 with L-carnitine L-tartrate, alpha-glucosyl hesperidin and sodium hyaluronate assessed scar appearance by Manchester Scoring Scale and skin texture by VISIOSCAN. The design had no control arm and the formulation was multi-ingredient, so GHK-Cu-specific effects cannot be isolated.

  5. 05سريري بشري2025

    A study comparing the effect of dermaroller versus dermaroller with copper peptide in the management of acne scars

    Vignesh NR, et al. · JCAS · comparative study, patients with facial acne scars treated with dermaroller alone or dermaroller plus a glycyl-L-histidyl-L-lysine (tripeptide-1) copper peptide serum, Goodman and Baron scoring up to 16 weeks; number of patients and allocation method not given in the abstract

    Differences between groups in the Goodman and Baron index were significant at baseline and week 3 but not from week 6 onward, and the authors judged long-term results similar. Because hyperpigmentation was more frequent with copper peptide, they concluded dermaroller alone can be a cost-effective standalone therapy.

    نتيجة سلامة مُبلغ عنها. Hyperpigmentation was more frequent in patients treated with copper peptide than with dermaroller alone.

  6. 06سريري بشري2024

    An Assessment of the Safety, Efficacy, and Tolerability of a Novel Scalp Treatment Regimen Combining a Hydroxy Acid-Based Scrub and Copper Tripeptide Serum in the Management of Seborrheic Dermatitis in Adults.

    Patel MN, et al. · Cureus · prospective, interventional, open-label, single-centre study in adults with mild to moderate dandruff

    A regimen pairing a hydroxy-acid scalp scrub with a copper tripeptide-1 serum was evaluated for Adherent Scalp Flaking Score, corneometry-measured scalp hydration, hair thickness and hair density. The study was uncontrolled and the serum contained several additional actives.

  7. 07سريري بشري2018

    Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study.

    Kapoor R, Shome D · J Cosmet Laser Ther · open-label prospective single-arm pilot, n=1000 patients with hair loss given intradermal scalp injections of a growth-factor formulation containing copper tripeptide-1 and thymosin β4, followed to 1 year

    Hair fall on the pull test fell significantly in 83% of patients, videomicroscopy showed fewer vellus and more terminal hairs in most, and total hair count was still significantly increased at 1 year (P = 0.002); treatment was reported as well tolerated. Copper tripeptide-1 was one of several actives in the formulation and there was no control group, so its own contribution cannot be separated.

  8. 08سريري بشري2016

    Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth.

    Lee WJ, et al. · Annals of Dermatology · placebo-controlled trial, n=45 men with pattern hair loss, three arms, once daily for 6 months

    Hair count increased by 52.6 in the high-dose arm and 71.5 in the low-dose arm versus 9.6 with placebo over 6 months, with the low-dose versus placebo ratio reaching statistical significance. No significant difference in hair length or thickness was found between groups and no adverse events were reported.

  9. 09سريري بشري2006

    Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.

    Miller TR, et al. · Archives of Facial Plastic Surgery · randomised controlled trial, n=13 completers, post-CO2 laser resurfacing regimen with or without GHK-Cu, 12-week follow-up

    Computer analysis and blinded evaluators found no statistically significant difference between groups in resolution of erythema, wrinkle improvement or overall skin appearance. A patient-completed questionnaire showed a significant difference favouring GHK-Cu for self-reported overall skin quality.

  10. 10سريري بشري1994

    Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper.

    Mulder GD, et al. · Wound Repair Regen · multicentre randomised evaluator-blinded vehicle-controlled trial, patients with diabetic neuropathic plantar ulcers, all on standardised wound care

    Topical GHK-Cu gel increased median ulcer closure to 98.5% versus 60.8% with vehicle and closure was about three times faster; the difference was larger for ulcers over 100 mm2. Ulcer infection incidence was 7% with GHK-Cu versus 34% with vehicle when treatment started immediately after debridement.

  11. 11سريري بشري1992

    A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers.

    Bishop JB, et al. · Journal of Vascular Surgery · prospective randomised evaluator-blinded trial, n=86 evaluable patients with venous stasis ulcers

    A 0.4% tripeptide-copper complex cream did not differ from inert vehicle placebo in ulcer size reduction, whereas 1% silver sulfadiazine cream significantly outperformed both. This remains the largest randomised human wound-healing trial of a copper tripeptide and was negative.

  12. 12حيواني داخل الجسم الحي2026

    The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.

    Wen H, et al. · Biogerontology · Caenorhabditis elegans lifespan and stress-resistance assays

    GHK-Cu extended lifespan in C. elegans and improved oxidative and thermal stress resistance, motility and pharyngeal pumping. The effects were linked to mitochondrial function and DAF-16/SKN-1 pathway activation.

  13. 13حيواني داخل الجسم الحي2024

    The glycyl-l-histidyl-l-lysine-Cu(2+) tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6.

    Bian Y, et al. · Redox Biology · crystalline-silica silicosis mouse model plus RAW264.7 alveolar macrophage cultures

    GHK-Cu reduced lung inflammation and fibrosis in silicosis mice without significant systemic toxicity, and peroxiredoxin 6 was identified as a direct binding target. The findings concern lung fibrosis rather than skin.

  14. 14حيواني داخل الجسم الحي1993

    In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds.

    Maquart FX, et al. · J Clin Invest · rat subcutaneous wound-chamber model, GHK-Cu injected at several concentrations versus saline and a control tripeptide

    GHK-Cu produced concentration-dependent increases in wound-chamber dry weight, DNA, total protein, collagen and glycosaminoglycans, with collagen synthesis stimulated twice as much as non-collagen protein. Type I and III collagen mRNAs rose while TGF-beta mRNA did not, and the control tripeptide had no effect.

  15. 15في المختبر2026

    Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu.

    Wang J, et al. · Skin Research and Technology · in vitro (LPS-stimulated macrophages), ex vivo skin, plus human application testing

    The combination of a Thermus thermophilus/Bacillus subtilis ferment extract with copper tripeptide-1 inhibited inflammatory cytokine secretion from LPS-stimulated macrophages more than either component alone. Effects were assessed across in vitro, ex vivo and clinical test arms.

  16. 16في المختبر2026

    A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis.

    Jeon S, et al. · Antioxidants (Basel) · TNF-alpha/IFN-gamma-stimulated HaCaT keratinocyte model of atopic dermatitis

    A Torilis japonica extract-GHK-Cu complex reduced expression of the atopic dermatitis-associated chemokines TARC/CCL17 and CTACK in stimulated keratinocytes and supported keratinocyte recovery. The work was confined to a cell-culture model.

  17. 17في المختبر2026

    Multi-Target Restoration of Dermal Elastic Fibers Through Elastin Upregulation, Elastase Suppression, and Scaffold Reinforcement.

    Ye S, et al. · Current Issues in Molecular Biology · human dermal fibroblast cultures; multi-ingredient comparison

    Copper tripeptide-1 increased elastin expression and secretion in dermal fibroblasts, while ethyl ferulate inhibited elastase activity and cedrol promoted scaffold-related gene expression. The three activities were characterised as complementary rather than interchangeable.

  18. 18في المختبر1988

    Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.

    Maquart FX, et al. · FEBS Letters · cultured fibroblasts, dose-response 10^-12 to 10^-9 M

    GHK-Cu stimulated collagen synthesis by fibroblasts beginning between 10^-12 and 10^-11 M and peaking at 10^-9 M, independently of any change in cell number. The authors noted a GHK triplet within the alpha-2(I) chain of type I collagen as a plausible endogenous source of the peptide.

  19. 19مراجعة2025

    Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.

    Mortazavi SM, et al. · BioImpacts · narrative review of GHK, GHK-Cu and palmitoyl-GHK for topical use

    The review concluded that published information on the skin permeability, effectiveness and physicochemical behaviour of GHK-Cu and Pal-GHK is insufficient despite their widespread use in marketed anti-wrinkle products.

  20. 20مراجعة2018

    Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.

    Pickart L, Margolina A · International Journal of Molecular Sciences · narrative review synthesising gene-expression datasets and prior GHK-Cu literature

    The review collated reports that GHK-Cu modulates large numbers of human genes involved in tissue remodelling, antioxidant defence and inflammation. It is a secondary source authored by a long-standing proponent of the peptide and is not itself experimental evidence.

  21. 21تقرير حالة2016

    Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation).

    Byun SY, et al. · J Cosmet Laser Ther · case report, one man aged 59 with crow's feet treated for 12 weeks with a copper-GHK-containing cosmetic solution delivered by the Jet-M jet device, with biopsies of treated and untreated skin

    Wrinkles around the treated eye decreased on clinical photographs, and biopsies showed more collagen in the upper dermis and increased fibrillin-1, procollagen type 1 and tropoelastin in treated skin. No adverse effect was reported. The solution also contained oligo-hyaluronic acid, rhodiolar extract, tranexamic acid and beta-glucan.

القيود

ما لا تثبته هذه الأدلة.

Controlled human evidence remains thin and inconsistent: the two largest randomised trials of topical copper tripeptide (venous ulcers 1992, post-laser skin 2006) found no significant benefit on objective endpoints, and a 2026 systematic review located only two RCTs of GHK-Cu as a standalone aesthetic intervention. Skin permeation of GHK-Cu from cosmetic vehicles is not well characterised, no dose-response for topical anti-wrinkle effect has been established in humans, and almost all positive human reports come from uncontrolled studies of multi-ingredient formulations.

أسئلة شائعة حول البحث.

What is GHK-Cu?

GHK-Cu is the copper complex of glycyl-L-histidyl-L-lysine, a naturally occurring tripeptide first isolated from human plasma. It is one of the most cited compounds in extracellular-matrix and skin-model research.

How does GHK-Cu relate to AHK-Cu?

Both are copper-binding tripeptides, but with different sequences and research focus. GHK-Cu dominates the extracellular-matrix and skin-remodelling literature, while AHK-Cu appears mainly in hair-follicle and dermal-papilla-cell models.

How strong is the controlled human evidence for GHK-Cu?

Thin and inconsistent. A 2026 PRISMA systematic review searching from database inception located only 20 studies of GHK-Cu as a standalone aesthetic intervention, of which 18 were preclinical and 2 were randomised controlled trials. Both of the largest randomised trials were negative: a 1992 evaluator-blinded trial in 86 evaluable patients with venous stasis ulcers found a 0.4 percent tripeptide-copper cream no different from inert vehicle, while silver sulfadiazine outperformed both, and a 2006 trial in 13 completers after CO2 laser resurfacing found no significant difference in erythema resolution, wrinkle improvement or overall skin appearance.

متاح من كتالوجنا

لأغراض البحث فقط. ليس للاستهلاك البشري أو التشخيص أو العلاج أو الوقاية من أي حالة. لا شيء في هذه الصفحة يعتبر نصيحة طبية، ولا ينبغي قراءة أي دراسة ملخصة هنا كتوصية.